Bloomberg Law
Feb. 3, 2020, 10:46 AM

State Drug-Pricing Laws Hampered by Resistance, Lack of Teeth

Brenna Goth
Brenna Goth
Staff Correspondent
Jacquie Lee
Jacquie Lee

State laws aimed at forcing the pharmaceutical industry to account for rising prescription-drug costs have done little to dampen price increases, in part because the companies skirt robust disclosure with relative impunity.

At least 11 states have laws requiring manufacturers to provide data on drugs’ costs, warnings before some prices increase, and justifications for changes. But many companies are complying only partly or not at all, saying the information is confidential under federal law, and some of the laws have few or no enforcement powers, Bloomberg Law found.

The companies’ actions come amid congressional gridlock over controlling prices and the ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.